Visani G - Search Results

1

Soft tissue and skeletal involvement in FIP1L1-PDGFR-alpha positive chronic eosinophilic leukemia: imatinib mesylate may induce complete molecular and imaging remission.

Malagola M, Martinelli G, Rondoni M, Ottaviani E, Piccaluga PP, Ricci P, Visani G, Baccarani M. Malagola M, et al. Among authors: visani g. Haematologica. 2004 Aug;89(8):ECR25. Haematologica. 2004. PMID: 15339694 No abstract available.

2

The achievement of molecular complete remission during treatment with imatinib mesylate correlates with relapse-free survival in bcr/abl-positive acute lymphoid leukemia patients.

Piccaluga PP, Malagola M, Amabile M, Rondoni M, Paolini S, Pane F, Russo D, Visani G, Baccarani M, Martinelli G. Piccaluga PP, et al. Among authors: visani g. Haematologica. 2004 Oct;89(10):1269-71. Haematologica. 2004. PMID: 15477218

3

Imatinib mesylate in the treatment of newly diagnosed or refractory/resistant c-KIT positive acute myeloid leukemia. Results of an Italian Multicentric Phase II Study.

Piccaluga PP, Malagola M, Rondoni M, Arpinati M, Paolini S, Candoni A, Fanin R, Messa E, Pirrotta MT, Lauria F, Visani G, Alberti D, Rancati F, Vinaccia V, Russo D, Saglio G, Baccarani M, Martinelli G. Piccaluga PP, et al. Among authors: visani g. Haematologica. 2007 Dec;92(12):1721-2. doi: 10.3324/haematol.11345. Haematologica. 2007. PMID: 18056005 Free article. Clinical Trial.

4

Real-time quantitation of minimal residual disease in inv(16)-positive acute myeloid leukemia may indicate risk for clinical relapse and may identify patients in a curable state.

Buonamici S, Ottaviani E, Testoni N, Montefusco V, Visani G, Bonifazi F, Amabile M, Terragna C, Ruggeri D, Piccaluga PP, Isidori A, Malagola M, Baccarani M, Tura S, Martinelli G. Buonamici S, et al. Among authors: visani g. Blood. 2002 Jan 15;99(2):443-9. doi: 10.1182/blood.v99.2.443. Blood. 2002. PMID: 11781223 Free article.

5

Complete remission in acute myeloid leukemia with granulocyte-colony stimulating factor without chemotherapy. Report of cytogenetic remission of a t(9;11)(p22q23) positive AML patient and review of literature.

Piccaluga PP, Martinelli G, Malagola M, Rondoni M, Bianchini M, Visani G, Baccarani M. Piccaluga PP, et al. Among authors: visani g. Haematologica. 2003 Aug;88(8):ECR28. Haematologica. 2003. PMID: 12935987 Review. No abstract available.

6

Association of 3q21q26 syndrome with different RPN1/EVI1 fusion transcripts.

Martinelli G, Ottaviani E, Buonamici S, Isidori A, Borsaru G, Visani G, Piccaluga PP, Malagola M, Testoni N, Rondoni M, Nucifora G, Tura S, Baccarani M. Martinelli G, et al. Among authors: visani g. Haematologica. 2003 Nov;88(11):1221-8. Haematologica. 2003. PMID: 14607750

7

Low dose gemtuzumab ozogamicin for relapsed acute myeloid leukaemia in elderly.

Piccaluga PP, Martinelli G, Rondoni M, Malagola M, Ronconi S, Visani G, Baccarani M. Piccaluga PP, et al. Among authors: visani g. Haematologica. 2003 Dec;88(12):ECR37. Haematologica. 2003. PMID: 14688010 No abstract available.

8

Anti-leukemic and anti-GVHD effects of campath-1H in acute lymphoblastic leukemia relapsed after stem-cell transplantation.

Piccaluga PP, Martinelli G, Malagola M, Rondoni M, Bianchini M, Vigna E, Bosi C, Gaitani S, Visani G, Baccarani M. Piccaluga PP, et al. Among authors: visani g. Leuk Lymphoma. 2004 Apr;45(4):731-3. doi: 10.1080/10428190310001603948. Leuk Lymphoma. 2004. PMID: 15160947

9

Gemtuzumab ozogamicin for relapsed and refractory acute myeloid leukemia and myeloid sarcomas.

Piccaluga PP, Martinelli G, Rondoni M, Malagola M, Gaitani S, Isidori A, Bonini A, Gugliotta L, Luppi M, Morselli M, Sparaventi G, Visani G, Baccarani M. Piccaluga PP, et al. Among authors: visani g. Leuk Lymphoma. 2004 Sep;45(9):1791-5. doi: 10.1080/1042819042000219485. Leuk Lymphoma. 2004. PMID: 15223637 Clinical Trial.

10

First experience with gemtuzumab ozogamicin plus cytarabine as continuous infusion for elderly acute myeloid leukaemia patients.

Piccaluga PP, Martinelli G, Rondoni M, Malagola M, Gaitani S, Visani G, Baccarani M. Piccaluga PP, et al. Among authors: visani g. Leuk Res. 2004 Sep;28(9):987-90. doi: 10.1016/j.leukres.2004.01.009. Leuk Res. 2004. PMID: 15234577 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

378 results

Search Page

Filters